Literature DB >> 15920224

Residual paralysis at the time of tracheal extubation.

Glenn S Murphy1, Joseph W Szokol, Jesse H Marymont, Mark Franklin, Michael J Avram, Jeffery S Vender.   

Abstract

Respiratory and pharyngeal muscle function are impaired during minimal neuromuscular blockade. Tracheal extubation in the presence of residual paresis may contribute to adverse respiratory events. In this investigation, we assessed the incidence and severity of residual neuromuscular block at the time of tracheal extubation. One-hundred-twenty patients presenting for gynecologic or general surgical procedures were enrolled. Neuromuscular blockade was maintained with rocuronium (visual train-of-four [TOF] count of 2) and all subjects were reversed with neostigmine at a TOF count of 2-4. TOF ratios were quantified using acceleromyography immediately before tracheal extubation, after clinicians had determined that complete neuromuscular recovery had occurred using standard clinical criteria (5-s head lift or hand grip, eye opening on command, acceptable negative inspiratory force or vital capacity breath values) and peripheral nerve stimulation (no evidence of fade with TOF or tetanic stimulation). TOF ratios were measured again on arrival to the postanesthesia care unit. Immediately before tracheal extubation, the mean TOF ratio was 0.67 +/- 0.2; among the 120 patients, 70 (58%) had a TOF ratio <0.7 and 105 (88%) had a TOF ratio <0.9. Significantly fewer patients had TOF ratios <0.7 (9 subjects, 8%) and <0.9 (38 subjects, 32%) in the postanesthesia care unit compared with the operating room (P < 0.001). Our results suggest that complete recovery from neuromuscular blockade is rarely present at the time of tracheal extubation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920224     DOI: 10.1213/01.ANE.0000151159.55655.CB

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  14 in total

1.  A randomized-controlled trial of sugammadex versus neostigmine: impact on early postoperative strength.

Authors:  Ramon E Abola; Jamie Romeiser; Sabeen Rizwan; Brandon Lung; Ruchir Gupta; Elliott Bennett-Guerrero
Journal:  Can J Anaesth       Date:  2020-05-13       Impact factor: 5.063

2.  A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada.

Authors:  Ralph P Insinga; Cédric Joyal; Alexandra Goyette; André Galarneau
Journal:  BMC Anesthesiol       Date:  2016-11-16       Impact factor: 2.217

3.  Recovery and prediction of postoperative muscle power - is it still a problem?

Authors:  Martin Zoremba; Dennis Kornmann; Benjamin Vojnar; Rene Burchard; Thomas Wiesmann; Hinnerk Wulf; Thomas Kratz
Journal:  BMC Anesthesiol       Date:  2017-08-22       Impact factor: 2.217

4.  Quantitative Relationships between Pulmonary Function and Residual Neuromuscular Blockade.

Authors:  ShuYing Fu; WenDong Lin; XiNing Zhao; ShengJin Ge; ZhangGang Xue
Journal:  Biomed Res Int       Date:  2018-02-15       Impact factor: 3.411

5.  Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review.

Authors:  Khawaja Rashid Hafeez; Arvind Tuteja; Mandeep Singh; David T Wong; Mahesh Nagappa; Frances Chung; Jean Wong
Journal:  BMC Anesthesiol       Date:  2018-07-19       Impact factor: 2.217

6.  Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent.

Authors:  Mark Welliver; John McDonough; Nicholas Kalynych; Robert Redfern
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

7.  Comparison between the Effects of Rocuronium, Vecuronium, and Cisatracurium Using Train-of-Four and Clinical Tests in Elderly Patients.

Authors:  Ozlem Sagir; Funda Yucesoy Noyan; Ahmet Koroglu; Muslum Cicek; Huseyin Ilksen Toprak
Journal:  Anesth Pain Med       Date:  2013-03-26

Review 8.  Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade.

Authors:  Stephan R Thilen; Sanjay M Bhananker
Journal:  Curr Anesthesiol Rep       Date:  2016-03-22

9.  The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review.

Authors:  Guangyu Liu; Rui Wang; Yanhong Yan; Long Fan; Jixiu Xue; Tianlong Wang
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

Review 10.  Neuromuscular blockade management in the critically Ill patient.

Authors:  J Ross Renew; Robert Ratzlaff; Vivian Hernandez-Torres; Sorin J Brull; Richard C Prielipp
Journal:  J Intensive Care       Date:  2020-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.